Micro- and Nanoparticles for Treating Cardiovascular Disease.
Micro- and Nanoparticles for Treating Cardiovascular Disease.
复制标题
DOI：
10.1039/c4bm00441h
复制
发表时间：
2015-04
影响因子：
6.6
通讯作者：
Christman KL
中科院分区：
文献类型：
--
作者：
Suarez S;Almutairi A;Christman KL
Cardiovascular disease, including myocardial infarction (MI) and peripheral artery disease (PAD), afflicts millions of people in Unites States. Current therapies are insufficient to restore blood flow and repair the injured heart or skeletal muscle, respectively, which is subjected to ischemic damage following vessel occlusion. Micro- and nano-particles are being designed as delivery vehicles for growth factors, enzymes and/or small molecules to provide a sustained therapeutic stimulus at the injured tissue. Depending on the formulation, the particles can be injected directly into the heart or skeletal muscle, or accumulate at the site of injury following an intravenous injection. In this article we review existing particle based therapies for treating MI and PAD.
